CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL]PYRIMIDINE-2,4-DIAMINE

Novel crystalline forms of brigatinib, pharmaceutical compositions comprising the same, and methods of their preparation and use of the same are disclosed herein.

Saved in:
Bibliographic Details
Main Authors SHARMA, PRADEEP, ROZAMUS, LEONARD, W
Format Patent
LanguageEnglish
Serbian
Published 30.09.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Novel crystalline forms of brigatinib, pharmaceutical compositions comprising the same, and methods of their preparation and use of the same are disclosed herein.
AbstractList Novel crystalline forms of brigatinib, pharmaceutical compositions comprising the same, and methods of their preparation and use of the same are disclosed herein.
Author ROZAMUS, LEONARD, W
SHARMA, PRADEEP
Author_xml – fullname: SHARMA, PRADEEP
– fullname: ROZAMUS, LEONARD, W
BookMark eNqFi80KgkAcxD3Uoa9XCI8G_SF1y7Ppyi7sh-x6aAsRie0UKtitx-iF0_DeYZj5MTNLZ9a0jV04n0QZXcSMUYHdTCquXZm5R0gIk0qCQHCDALyUclwQw3Ii9SBl2M7NCRaGlSACeAcw9vJiYDgg8BBMe5pjFV-pAB9-n5FpOnGZG0X5iBiCPYKUxnzIa2f-qJ-93Uy-crYZLhICtmsr23f13Tb2VSl9OkRhdPbDv4MvCZJBtQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate KRISTALNI OBLICI 5-HLORO-N4-[-2-(DIMETILFOSFORIL)FENIL]-N2-{2-METOKSI-4-[4-(4-METILPIPERAZIN-1-IL)PIPERIDIN-1-IL]PIRIMIDIN-2,4-DIAMINA
ExternalDocumentID RS60737B1
GroupedDBID EVB
ID FETCH-epo_espacenet_RS60737B13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:04:30 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Serbian
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_RS60737B13
Notes Application Number: RS2020P001049
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200930&DB=EPODOC&CC=RS&NR=60737B1
ParticipantIDs epo_espacenet_RS60737B1
PublicationCentury 2000
PublicationDate 20200930
PublicationDateYYYYMMDD 2020-09-30
PublicationDate_xml – month: 09
  year: 2020
  text: 20200930
  day: 30
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies ARIAD PHARMACEUTICALS, INC
RelatedCompanies_xml – name: ARIAD PHARMACEUTICALS, INC
Score 3.2978535
Snippet Novel crystalline forms of brigatinib, pharmaceutical compositions comprising the same, and methods of their preparation and use of the same are disclosed...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL]PYRIMIDINE-2,4-DIAMINE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200930&DB=EPODOC&locale=&CC=RS&NR=60737B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT4MwEG-WadQ3v78XHgyZiRcNA7Y9ELNBCRgGpKAZmmVZ-TC-bMuG8cE_w3_YA5n6soc2vZY26ZXr9dder4RcyW0lSbO4A0qiKiCnky7wbjtDcVeTNJbULElKK19XtR7lh6EyrJHX1V2Y0k_oR-kcESUqRnnPy_l6_reJZZS2lctb_oZZs3sz1AyxQsfFVn_rTjT6GvU9w9NFXddYILpMU_FXbvcRJm0Ua-jCyT596hdXUub_9Ym5SzZ9bGqa75HacrFPtvXVs2v7ZGtQnXZjshK85QH50lkUhD1E3i4VELgNAsEzBQV0y_GYB64MLyBB07AHNLQix7e8AAOLnGvBt6gbOSNwJfiUoCj3hhFgBRmaMlTf2z5lvWfbRahX1ilo26jokR8xnOOQpCDdyGAg_Mf0IWmYNNQtwN6Nf_k4ZkHFhdYRqU9n0_SECJzLscQzzmNcOXVQe_OkyzsTjCQEg0l2So7XNHK2tuSc7BRD8WNVcUHq-eI9vUTVnfNGyfZvOfKVFA
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3JTsMwELWqgig3KPtSckBRkRiB0iztIUJtFiWQTUlADaiq6iyIS1u1QRz4DH6YSUiBSw-xPHZsyWOPx88ejwm55CUhSbO4C0IiCsCnkx7QnpShuItJGnNiliSlla8jGo_8_VAY1sjr6i5M6Sf0o3SOiBIVo7zn5Xw9_9vEUkvbyuUNfcOk2Z0eyipboeNiq79zy6oDWfNc1VVYRZH9gHV8WcShLA0QJm1IiAcLJ_va06C4kjL_r0_0HbLpYVXTfJfUlosmaSirZ9eaZMuuTrsxWgneco98KX4UhH1E3o7GIHCzA8bVGQEUw3J9FxweXoCDtmraWmhElme4AX5-ZF0xnqE5kTUCh4NPDop8dxgBFuChzUP1v-lpfv_ZdBDqlWUK2lQreuRFPs5xSGrAXfOgIvzH-D5p6VqoGICtG__ycewHFRc6B6Q-nU3TI8JQyscczSiNceXURe1Nkx7tTjDgEAwm2TE5XFPJydqcC9IwQtsaI0seTsl20S0_FhZnpJ4v3tNzVOM5bZVd8A1ZsZf_
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CRYSTALLINE+FORMS+OF+5-CHLORO-N4-%5B-2-%28DIMETHYLPHOSPHORYL%29+PHENYL%5D-N2-%7B2-METHOXY-4-%5B4-%284-METHYLPIPERAZIN-1-YL%29+PIPERIDIN-1-YL%5DPYRIMIDINE-2%2C4-DIAMINE&rft.inventor=SHARMA%2C+PRADEEP&rft.inventor=ROZAMUS%2C+LEONARD%2C+W&rft.date=2020-09-30&rft.externalDBID=B1&rft.externalDocID=RS60737B1